Eupraxia Pharmaceuticals Inc. (EPRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Eupraxia Pharmaceuticals Inc., updated every trading day.
Health Care · Pharmaceuticals and Biotechnology
Price
$7.38
+4.24% today
Market cap
$467M
Overall quality
47/100
Kronos AI 30-day
−4.4%
4 of 8 simulated paths end higher
Eupraxia Pharmaceuticals Inc. (EPRX) is a Health Care company in Pharmaceuticals and Biotechnology, worth $467M. It trades at $7.38, up 4.24% today. Its overall quality score is 47 out of 100, ranked against the whole US market. 8 analysts' average target of $17.00 implies +130.4% from today's price. Kronos AI's 30-day forecast is −4.4% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $17.00 |
| Low – high | $11.00 – $25.00 |
| Analysts | 8 |
| Upside to average | +130.4% |
Kronos AI 30-day forecast
| Expected close | $6.77 (−4.4%) |
| Likely range | −11.1% … +10.1% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 57 |
| Growth | 44 |
| Overall | 47 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
For information only, not investment advice. Prices updated: 2026-10-29.